Bumrungrad Hospital PCLBUGDF 100 EBITDA Margin % is 39.82% as of Dec. 2025, which is 16% above its 10-year median of 34.27. GuruFocus rates BUGDF with a GF Score™ of 100/100 and a GF Value™ of $5.86. The stock has 1 warning sign investors should review. Among 668 Healthcare Providers & Services companies, Bumrungrad Hospital PCL ranks better than 96.11% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Bumrungrad Hospital PCL EBITDA Margin % Related Terms
Bumrungrad Hospital PCL EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BUGDF vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bumrungrad Hospital PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Bumrungrad Hospital PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bumrungrad Hospital PCL (BUGDF) has a EBITDA Margin % of 39.82% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bumrungrad Hospital PCL and its competitors. This is 16% above median its historical median of 34.27. Over the past decade, Bumrungrad Hospital PCL's EBITDA Margin % has ranged from 21.99 to 41.15. According to the industry distribution chart, Bumrungrad Hospital PCL ranks #26 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 3.9%.
Is Bumrungrad Hospital PCL's EBITDA Margin % too high?
Bumrungrad Hospital PCL's current EBITDA Margin % of 39.82% is 16% above median its 10-year median of 34.27. Over the past 10 years, this metric has ranged from a low of 21.99 to a high of 41.15. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Bumrungrad Hospital PCL's value of 39.82% is 290% above this industry median. Based on the distribution chart, Bumrungrad Hospital PCL ranks #26 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Bumrungrad Hospital PCL has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bumrungrad Hospital PCL ranks #26 out of 668 companies for EBITDA Margin %. This places Bumrungrad Hospital PCL in the top 4% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Bumrungrad Hospital PCL's value of 39.82% is 290% above this benchmark. Historically, Bumrungrad Hospital PCL's own EBITDA Margin % has ranged from 21.99 to 41.15 over the past decade. While the company's 10-year median is 34.27 vs. the industry median of 10.21, Bumrungrad Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bumrungrad Hospital PCL's current EBITDA Margin % of 39.82% is 290% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bumrungrad Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bumrungrad Hospital PCL's current EBITDA Margin % is 39.82%, which is 16% above median its own 10-year median of 34.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current EBITDA Margin % of 39.82%. The stock's GF Value™ is $5.86, compared to a current price of $4.75 — trading 18.9% below its estimated fair value. The current EBITDA Margin % is 39.82%, which is 16% above median its 10-year median of 34.27 and 290% above the Healthcare Providers & Services industry median of 10.21. Bumrungrad Hospital PCL's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current EBITDA Margin % is 39.82% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?
Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued.
The current stock price of $4.75 is trading 18.9% below its estimated GF Value™ of $5.86.
Key valuation signals for BUGDF:
EBITDA Margin %: 39.82% (16% above median its 10-year median of 34.27)
GF Value™: $5.86 vs. price of $4.75 (18.9% below fair value)
Industry Position: 290% above the Healthcare Providers & Services median (#26 of 668)
No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
100GF Score
Get the complete analysis for BUGDF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUGDF has been successfully added to your 
